S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities

ImmunityBio (IBRX) SEC Filings & 10K Form

$4.91
-0.33 (-6.30%)
(As of 04/18/2024 ET)

Recent ImmunityBio SEC Filings

DateFilerForm TypeView
04/17/2024
4:24 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3ASR
03/28/2024
8:14 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2024
3:31 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
3:40 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:43 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:36 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:38 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
8:28 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
8:14 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:38 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:32 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:33 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:59 PM
Cambridge Equities, LP (Filed by)
ImmunityBio, Inc. (Subject)
ImmunityBio (Subject)
Form SC 13D/A
01/03/2024
8:53 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Nant Capital, LLC (Reporting)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:40 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
8:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
5:08 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
3:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
8:28 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2023
5:06 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEF 14C
09/22/2023
2:06 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form D
Notice of Exempt Offering of Securities 
09/21/2023
3:25 PM
Cambridge Equities, LP (Filed by)
ImmunityBio, Inc. (Subject)
ImmunityBio (Subject)
Form SC 13D/A
09/15/2023
6:30 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form PRE 14C
09/13/2023
8:07 PM
CALIFORNIA CAPITAL EQUITY, LLC (Reporting)
Cambridge Equities, LP (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MP 13 Ventures, LLC (Reporting)
Nant Capital, LLC (Reporting)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
5:25 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
6:39 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:40 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:41 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
7:30 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
7:58 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
8:00 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
8:01 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
4:12 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 424B5
07/21/2023
5:04 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:45 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:25 PM
Brennan John Owen (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:27 PM
Clark Wesley (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:28 PM
Cohen Cheryl (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:29 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MAXWELL LINDA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:30 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Selecky Christobel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
3 Sub-$10 Stocks to Buy for 2024 (Ad)

Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.

Get your FREE look at these THREE companies right here.
06/15/2023
5:24 PM
BLASZYK MICHAEL D (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:15 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
8:52 PM
BLASZYK MICHAEL D (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
6:55 PM
Brennan John Owen (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
6:54 PM
Clark Wesley (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
7:30 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
5:45 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
5:47 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2023
3:24 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEF 14A
04/28/2023
3:26 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IBRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners